BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2692357)

  • 1. [Melanoma as a possible complication of the treatment of parkinsonism with L-dopa preparations (review of the literature)].
    Kande'l EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):126-7. PubMed ID: 2692357
    [No Abstract]   [Full Text] [Related]  

  • 2. [Malignant melanoma and L-dopa. Review of literature on the problem of causal relationship].
    Happle
    Fortschr Med; 1974 Sep; 92(27):1065-6. PubMed ID: 4457419
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.
    Pfützner W; Przybilla B
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):332-6. PubMed ID: 9270541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
    Zanetti R; Loria D; Rosso S
    Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease, levodopa-use and the risk of melanoma.
    Vermeij JD; Winogrodzka A; Trip J; Weber WE
    Parkinsonism Relat Disord; 2009 Sep; 15(8):551-3. PubMed ID: 19501540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Letter: Malignant melanoma during treatment with levodopa].
    Pelfréne AF
    Nouv Presse Med; 1975 May; 4(18):1365. PubMed ID: 1153302
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature.
    Kochar AS
    Am J Med; 1985 Jul; 79(1):119-21. PubMed ID: 4014296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa therapy and malignant melanoma.
    Sober AJ; Wick MM
    JAMA; 1978 Aug; 240(6):554-5. PubMed ID: 671667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma].
    Kleinhans M; Schmid-Grendelmeier P; Burg G
    Hautarzt; 1996 Jun; 47(6):432-7. PubMed ID: 8767657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa and melanoma: three cases and review of literature.
    Rampen FH
    J Neurol Neurosurg Psychiatry; 1985 Jun; 48(6):585-8. PubMed ID: 4009196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa and malignant melanoma.
    Robinson E; Wajsbort J; Hirshowitz B
    Arch Pathol; 1973 Mar; 95(3):213. PubMed ID: 4686512
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinson's disease, melanoma, and levodopa.
    Fermaglich J; Delaney P
    J Neurol; 1977 Jun; 215(3):221-4. PubMed ID: 69691
    [No Abstract]   [Full Text] [Related]  

  • 13. [Melanoma while using levodopa due to Parkinson's disease--causal association unlikely].
    Wobbes T; Bonenkamp JJ
    Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1286-8. PubMed ID: 12138675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?
    Fiala KH; Whetteckey J; Manyam BV
    Parkinsonism Relat Disord; 2003 Aug; 9(6):321-7. PubMed ID: 12853231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risks in the treatment of parkinsonism with l-dopa and a dopa decarboxylase inhibitor].
    Jörg J
    Med Welt; 1979 Nov; 30(46):1740-2. PubMed ID: 537499
    [No Abstract]   [Full Text] [Related]  

  • 16. Melanoma and levodopa.
    Rampen F
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):782-4. PubMed ID: 9591833
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of two malignant melanomas during administration of levodopa.
    Przybilla B; Schwab U; Landthaler M; Braun-Falco O
    Acta Derm Venereol; 1985; 65(6):556-7. PubMed ID: 2420127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa administration and multiple primary cutaneous melanomas.
    Bernstein JE; Medenica M; Soltani K; Solomon A; Lorincz AL
    Arch Dermatol; 1980 Sep; 116(9):1041-44. PubMed ID: 7416757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-dopa, parkinsonism, and involuntary movements.
    Mayer RF
    Trans Am Neurol Assoc; 1974; 99():163-6. PubMed ID: 4463527
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of dihydroergotamine in the prevention and treatment of orthostatic hypotension syndromes in patients with parkinsonism treated with L-dopa].
    Jubert Gruart J; Balcells Riba M
    Arch Neurobiol (Madr); 1974; 37(4):401-12. PubMed ID: 4433212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.